Spindletop Health Acquisition Corp. Warrant
SHCAW
SHCAW was delisted on the 27th of December, 2022.
0 hedge funds and large institutions have $0 invested in Spindletop Health Acquisition Corp. Warrant in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 43 closing their positions.
100% less funds holding
Funds holding: 43 → 0 (-43)
100% less capital invested
Capital invested by funds: $2.11M → $0 (-$2.11M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 43
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$1.57M |
| 2 |
SCM
Saba Capital Management
New York
|
-$47K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$40K |
| 4 |
TCA
Taconic Capital Advisors
New York
|
-$33K |
| 5 |
P3I
Progeny 3 Inc
Kirkland,
Washington
|
-$30K |
SHCAW Hedge Fund Activity: Q4 2022 in Review
0 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Spindletop Health Acquisition Corp. Warrant (SHCAW) for Q4 2022, worth a combined $0 — down 100% from $2.11M a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of SHCAW and 0 opened new positions — a net loss of 43 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $1.57M sold.
- 0 institutional investors held Spindletop Health Acquisition Corp. Warrant (SHCAW) as of Q4 2022, down from 43 in Q3 2022.
- Funds reported $0 of Spindletop Health Acquisition Corp. Warrant stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Spindletop Health Acquisition Corp. Warrant positions in Q4 2022 and 43 closed out, a net change of -43 holders.
- The largest Spindletop Health Acquisition Corp. Warrant seller in Q4 2022 was Radcliffe Capital Management, an estimated $1.57M sold.
Based on aggregated 13F filings for Q4 2022.